Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Amit Sanyal, MD: A Clinician’s Perspective

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Oct
20
Today In Oncology
Community Oncology Practices Bring Advances in Cancer Testing and Treatment Closer to Patients
FDA Approves Atezolizumab in Combination With Chemotherapy for Stage III dMMR Colon Cancer
FDA Approves Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Mocertatug Rezetecan (Mo-Rez) Shows Early Activity in Platinum-Resistant Ovarian and Endometrial Cancers
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo